Dr Thomas Cade
Clinical (Senior Fellow)
Department of Obstetrics, Gynaecology and Newborn Health
33 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
Can maternal serum soluble fms-like tyrosine kinase-1 to placental growth factor levels at term anticipate adverse pregnancy outcomes?
DOI: 10.1111/jog.161912024
Journal article
Ophthalmic ultrasound in the prediction of preeclampsia
DOI: 10.1016/j.preghy.2024.01.0492024
Journal article
Low-risk gestational trophoblastic neoplasia – 20 years experience of a state registry
DOI: 10.1111/ajo.137722024
Journal article
Maternal serum soluble fms-like tyrosine kinase-1–to–placental growth factor ratio distinguishes growth-restricted from non–growth-restricted small-for-gestational-age fetuses
DOI: 10.1016/j.xagr.2023.1003022023
Journal article
PO9_03. Maternal ocular sonography: A window into the cerebral effects of antihypertensive therapy in preeclampsia
DOI: 10.1016/j.preghy.2023.07.0992023
Journal article
PO6_25. Is there a fetal sex-based influence on maternal serum SFLT-1, PLGF and SFLT-1/PLGF ratio levels during the latter half of human pregnancy?
DOI: 10.1016/j.preghy.2023.07.0822023
Journal article
Cord blood effectively resists mineralization through mechanisms that stabilize calciprotein particles
DOI: 10.1016/j.kint.2022.11.019
RECENT SCHOLARLY WORKS
2023
Journal article
Risk factors for acute colonic pseudo-obstruction after caesarean section: A retrospective case–control study
DOI: 10.1111/ajo.135832023
Journal article
Identification of biochemical biomarkers associated with premature cervical shortening in high-risk, asymptomatic pregnant women: a retrospective data analysis
DOI: 10.1080/01443615.2023.22122992022
Conference Proceedings
Clinical Utility of the Soluble FMS-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio in Term Pregnancies for Predicting Adverse Perinatal Outcomes: A Retrospective Analysis